Pacritinib M2 Metabolite
| Catalog No. | KMP032006 |
|---|---|
| CAS No. | NA |
| Formula | C22H21N3O3 |
| FW | 375.4 |
| Unit | Price | Stock |
|---|---|---|
| 100 mg | Enquire | Enquire |
| Chemical Name: | (E)-6,11-dioxa-3-aza-2(4,2)-pyrimidina-1,4(1,3)-dibenzenacyclododecaphan-8-en-44-ol |
|---|---|
| Purity: | >95% |
| Storage: | Store at 2-8 deg. C for long term storage |
| Shipping: | Product is stable to be Shipped at Room Temperature |
| Usage Disclaimer: | All products supplied are intended strictly for laboratory research, analytical, and scientific purposes only. They are not intended for human or veterinary consumption, medical use, or diagnostic applications. |
Pacritinib M2 Metabolite is chemically (E)-6,11-dioxa-3-aza-2(4,2)-pyrimidina-1,4(1,3)-dibenzenacyclododecaphan-8-en-44-ol .
Pacritinib M2 Metabolite is supplied with detailed characterization data compliant with regulatory guideline.
Pacritinib M2 Metabolite can be used for the analytical method development, method validation (AMV), Quality Controlled (QC)
application for Abbreviated New Drug Application (ANDA) or during commercial production of Pacritinib M2 Metabolite.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. K.M.Pharma products are for analytical purpose only and not for human use.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. K.M.Pharma products are for analytical purpose only and not for human use.
Related Products
CAT No: KMP032001
CAT No: KMP032002
CAT No: KMP032003
CAT No: KMP032004
CAT No: KMP032005